Tivic Health Systems, Inc. (TIVC)
$0.7378
+0.04 (+5.42%)
Rating:
Recommendation:
-
| Symbol | TIVC |
|---|---|
| Price | $0.7378 |
| Beta | 0.000 |
| Volume Avg. | 0.05M |
| Market Cap | 7.140M |
| Shares () | - |
| 52 Week Range | 0.51-2.87 |
| 1y Target Est | - |
| DCF Unlevered | TIVC DCF -> | |
|---|---|---|
| DCF Levered | TIVC LDCF -> | |
| ROE | -125.28% | Strong Sell |
| ROA | -95.64% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | 42.20% | Neutral |
| P/E | - | |
| P/B | 1.24 | Strong Buy |
Latest TIVC news
About
Download (Excel)Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.